Humana Inc Expected to Earn Q3 2018 Earnings of $4.42 Per Share (HUM)

Share on StockTwits

Humana Inc (NYSE:HUM) – Equities researchers at Jefferies Financial Group increased their Q3 2018 EPS estimates for Humana in a research note issued on Wednesday, August 1st, according to Zacks Investment Research. Jefferies Financial Group analyst D. Windley now anticipates that the insurance provider will earn $4.42 per share for the quarter, up from their previous forecast of $4.12. Jefferies Financial Group currently has a “Buy” rating and a $372.00 target price on the stock. Jefferies Financial Group also issued estimates for Humana’s Q4 2018 earnings at $2.51 EPS, FY2018 earnings at $14.25 EPS and FY2019 earnings at $17.45 EPS.

Other analysts have also recently issued reports about the company. Zacks Investment Research cut Humana from a “buy” rating to a “hold” rating in a research report on Wednesday, August 8th. Citigroup restated a “buy” rating and issued a $340.00 price objective (up from $280.00) on shares of Humana in a research report on Friday, June 1st. Argus boosted their price objective on Humana from $270.00 to $330.00 and gave the company a “buy” rating in a research report on Monday, April 16th. Oppenheimer boosted their price objective on Humana from $305.00 to $311.00 and gave the company an “outperform” rating in a research report on Thursday, May 3rd. Finally, Royal Bank of Canada restated a “hold” rating and issued a $318.00 price objective on shares of Humana in a research report on Thursday, August 2nd. Seven research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus target price of $318.17.

Humana stock opened at $324.07 on Monday. The company has a market capitalization of $44.78 billion, a PE ratio of 27.67, a price-to-earnings-growth ratio of 1.62 and a beta of 0.93. Humana has a 12 month low of $231.90 and a 12 month high of $327.50. The company has a debt-to-equity ratio of 0.47, a current ratio of 1.43 and a quick ratio of 1.43.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, August 1st. The insurance provider reported $3.96 earnings per share for the quarter, beating the consensus estimate of $3.79 by $0.17. The company had revenue of $14.26 billion during the quarter, compared to analysts’ expectations of $14.16 billion. Humana had a return on equity of 17.43% and a net margin of 2.48%. During the same period last year, the business earned $3.49 earnings per share.

In other Humana news, SVP Cynthia H. Zipperle sold 1,000 shares of the business’s stock in a transaction on Wednesday, June 13th. The stock was sold at an average price of $306.01, for a total transaction of $306,010.00. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Elizabeth D. Bierbower sold 6,036 shares of the business’s stock in a transaction on Monday, June 11th. The stock was sold at an average price of $300.91, for a total value of $1,816,292.76. Following the transaction, the insider now directly owns 21,683 shares in the company, valued at approximately $6,524,631.53. The disclosure for this sale can be found here. Insiders have sold 104,976 shares of company stock worth $32,165,337 in the last three months. 0.60% of the stock is currently owned by corporate insiders.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Raymond James Trust N.A. boosted its stake in Humana by 19.8% during the second quarter. Raymond James Trust N.A. now owns 956 shares of the insurance provider’s stock worth $284,000 after buying an additional 158 shares during the last quarter. Trust Co boosted its stake in Humana by 7.7% during the first quarter. Trust Co now owns 2,326 shares of the insurance provider’s stock worth $625,000 after buying an additional 167 shares during the last quarter. Daiwa SB Investments Ltd. boosted its stake in Humana by 27.9% during the second quarter. Daiwa SB Investments Ltd. now owns 780 shares of the insurance provider’s stock worth $232,000 after buying an additional 170 shares during the last quarter. Advisor Partners LLC lifted its stake in shares of Humana by 5.3% in the 2nd quarter. Advisor Partners LLC now owns 3,604 shares of the insurance provider’s stock valued at $1,073,000 after purchasing an additional 180 shares during the last quarter. Finally, Oppenheimer Asset Management Inc. lifted its stake in shares of Humana by 1.7% in the 2nd quarter. Oppenheimer Asset Management Inc. now owns 11,901 shares of the insurance provider’s stock valued at $3,541,000 after purchasing an additional 197 shares during the last quarter. 93.40% of the stock is currently owned by institutional investors.

Humana Company Profile

Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company operates through four segments: Retail; Group and Specialty; Healthcare Services; and Individual Commercial. The Retail segment offers Medicare and supplemental benefit plans to individuals or through group accounts.

Featured Article: Find a Trading Strategy That Works

Get a free copy of the Zacks research report on Humana (HUM)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.